{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:48Z","timestamp":1787169648661,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Rhino-orbital-cerebral mucormycosis (ROCM) is a rare opportunistic fungal infection with a fulminant course and an often fatal outcome. It can occur in immune-compromised patients such as those having uncontrolled diabetes, on long-term corticosteroid or immunosuppressive therapy, with COVID-19 infection, renal failure, AIDS, malignancy, or organ transplant. The aim of our study was to study the epidemiology of mucormycosis in COVID-19 patients and identify its risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Ours was an epidemiological study wherein we gathered the demographic, clinical, histopathological, and radiological data of 458 patients of mucormycosis who presented to us between August 2020 and May 2021. Mucormycosis was defined through clinical and radiological findings or positive culture reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of all, 20.74% of patients did not have any past or concurrent history of COVID-19. The most common symptom of mucormycosis was orbital\/facial pain (38.64%) and the most common sign was periocular\/facial edema (50.74%). Mucormycosis involving the nose and sinuses (94.54%) was most common followed by rhino-orbital (45.41%) and brain involvement (10.04%). The most common risk factor for mucormycosis was diabetes [81.92%], followed by corticosteroid use [79.69%] and supplemental oxygen [48.90%]. Most of the patients received similar treatment with IV amphotericin B [88.64%] and local debridement [80.74%]<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>With the third wave of COVID-19 still lurking, a fatal fungal infection should be kept in mind in COVID-19 active as well as recovered patients, especially those who have co-morbid medical conditions such as uncontrolled diabetes and who are treated with large doses of corticosteroids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2943_21","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T07:53:23Z","timestamp":1648454003000},"page":"1371-1375","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India"],"prefix":"10.4103","volume":"70","author":[{"given":"Ravija","family":"Patel","sequence":"first","affiliation":[{"name":"Glaucoma unit, Department of ophthalmology, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Jethva","sequence":"additional","affiliation":[{"name":"Glaucoma unit, Department of ophthalmology, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvi R","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Glaucoma unit, Department of ophthalmology, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Glaucoma unit, Department of ophthalmology, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansa","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Glaucoma unit, Department of ophthalmology, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Glaucoma unit, Department of ophthalmology, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","article-title":"Bacterial and fungal coinfection among hospitalized patients with COVID- 19: A retrospective cohort study in a UK secondary-care setting [published online ahead of print, 2020 Jun 27]","volume":"26","author":"Hughes","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"B4-20240828","first-page":"243","article-title":"Pulmonary defense mechanisms against opportunistic fungal pathogens","volume":"47","author":"Waldorf","year":"1989","journal-title":"Immunol Ser"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI111395","article-title":"Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defence mechanisms against Rhizopus","volume":"74","author":"Waldorf","year":"1984","journal-title":"J Clin Invest"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0973-029X.48743","article-title":"Rhinomaxillary mucormycosis with cerebral extension","volume":"13","author":"Goel","year":"2009","journal-title":"J Oral Maxillofac Pathol"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4103\/ccd.ccd_558_17","article-title":"Mucormycosis in a diabetic patient: A case report with an insight into its pathophysiology","volume":"8","author":"Afroze","year":"2017","journal-title":"Contemp Clin Dent"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2007.01364.x","article-title":"Rhinocerebralmucormycosis: The disease spectrum in 27 patients","volume":"50","author":"Mohindra","year":"2007","journal-title":"Mycoses"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.tripleo.2011.04.048","article-title":"Management and outcomes of three cases of rhinocerebralmucormycosis","volume":"112","author":"Viterbo","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B12-20240828","article-title":"Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report","author":"Veisi","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: Aclinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India-Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.4103\/ijo.IJO_2085_21","article-title":"COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre","volume":"69","author":"Walia","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4103\/ijo.IJO_1767_21","article-title":"Incidence, cumulative mortality and factor affecting the outcome of COVID-19 associated mucormycosis from western India","volume":"69","author":"Vare","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"867","DOI":"10.18203\/issn.2454-5929.ijohns20211583","article-title":"A case series of invasive mucormycosis in patients with COVID-19 infection","volume":"7","author":"Mishra","year":"2021","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"key":"B18-20240828","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2000","journal-title":"Cureus"},{"key":"B19-20240828","first-page":"64","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"264","author":"Werthman-Ehrenreich","year":"2021","journal-title":"Am J Emerg Med"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020","volume":"26","author":"Chowdhary","year":"2020","journal-title":"Emerg Infect Dis"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2943_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:00Z","timestamp":1787166600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2943_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2943_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"2021-11-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}